Last update:

Diseases, Conditions, Syndromes news

HIV & AIDS

A viral trapdoor: Scientists discover how a protein protects against HIV and herpes

A group of researchers discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex virus-1 by assembling structures in the cell that lure in these viruses and then trap them or even take ...

Diseases, Conditions, Syndromes

Survey: Most adults affected by suicide, want more prevention

Nearly all U.S. adults agree that more action can be taken to reduce suicide deaths, with about three-fifths also reporting they have been personally affected by suicide, according to national survey data released Wednesday.

Diseases, Conditions, Syndromes

Q&A: Researcher discusses what we've learned about long COVID

It has been more than four years since the COVID-19 pandemic began, yet millions of people continue to suffer long-term effects from the virus. Despite thousands of studies, many clinicians remain unsure of how to evaluate ...

Diseases, Conditions, Syndromes

Newly discovered COVID vaccine targets may last longer

Melbourne researchers have discovered more than 200 new vaccine target candidates from the COVID-19 virus, SARS-CoV-2, that could lead to the development of vaccines with a longer lasting broader immunity than existing vaccinations.

Oncology & Cancer

Rapid blood cancer diagnostic could speed decisions and save lives

Researchers at Dana-Farber Cancer Institute have created a CRISPR-based rapid molecular diagnostic for two forms of leukemia that are driven by mutations that involve gene fusions. The technology accurately detects the presence ...

Diseases, Conditions, Syndromes

Oral vaccines could provide relief for people who suffer regular UTIs

In a recent TikTok video, Australian media personality Abbie Chatfield shared she was starting a vaccine to protect against urinary tract infections (UTIs). "Huge news for the UTI girlies. I am starting a UTI vaccine tonight ...

Diseases, Conditions, Syndromes

Adrenaline auto-injectors may not prevent fatal anaphylaxis

Individuals at risk of anaphylaxis—an acute systemic hypersensitivity reaction to an allergen or trigger, typically associated with skin reactions, nausea/vomiting, difficulty breathing, and shock—are often prescribed ...

Diseases, Conditions, Syndromes

Uganda confirms mpox case in prison

Uganda on Wednesday confirmed a prison inmate has contracted mpox in a central area that is the epicenter of the outbreak in the East African country.

Diseases, Conditions, Syndromes

Extra virgin olive oil may delay cognitive decline in Down syndrome

Researchers working with the Alzheimer's Center at Temple (ACT) recently investigated the effect of extra virgin olive oil (EVOO) on brain health and memory to determine if consumption of extra virgin olive oil, the main ...

Diseases, Conditions, Syndromes

Long COVID symptoms found to be prevalent among health care workers

New research from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, and University College London has found that 33.6% of surveyed health care workers in England report symptoms consistent ...

Diseases, Conditions, Syndromes

CDC will test travelers from Rwanda for Ebola-like Marburg virus

As health officials work furiously to stem the spread of Marburg virus in Rwanda, U.S. health officials announced Monday that all passengers flying from that country to the United States will soon be screened for the often ...

Diseases, Conditions, Syndromes

Understanding symptoms: Is it hay fever, COVID or something else?

Hay fever (also called allergic rhinitis) affects 24% of Australians. Symptoms include sneezing, a runny nose (which may feel blocked or stuffy) and itchy eyes. People can also experience an itchy nose, throat or ears.

Diseases, Conditions, Syndromes

Consumer Health: What's the difference between heartburn and GERD?

Heartburn—that burning pain in your chest after eating certain foods or when you lie down in the evening—is a common complaint and usually no cause for alarm. Heartburn occurs when stomach acid backs up into the esophagus, ...

Diseases, Conditions, Syndromes

WHO declares end to Marburg virus outbreak in Equatorial Guinea

The UN's health agency on Thursday declared an end to a nearly four-month epidemic of Marburg virus in Equatorial Guinea, saying the disease, a cousin of Ebola, had caused 35 confirmed or suspected deaths.

Diseases, Conditions, Syndromes

EU approves first vaccine against common respiratory virus

The European Commission has followed the United States in approving the world's first vaccine for the Respiratory Syncytial Virus, to be used by adults aged 60 and over, its maker GlaxoSmithKline said Wednesday.

Diseases, Conditions, Syndromes

What is irritable bowel syndrome?

People who suffer from irritable bowel syndrome (IBS) know it is a highly unpleasant chronic condition that can trigger abdominal pain, diarrhea and constipation.

Diseases, Conditions, Syndromes

New algorithm sets parameters for waves of COVID-19

A method for defining different waves of COVID-19 to better understand the progression of the virus across the pandemic has been devised by a team of scientists at Cardiff University and the University of Oxford. They developed ...

Diseases, Conditions, Syndromes

Gonorrhea, syphilis on rise in England: UK health agency

England saw a record number of gonorrhea cases and the highest level of syphilis in decades last year as sexually transmitted infections (STIs) spiked, the UK Health Security Agency said on Tuesday.

Diseases, Conditions, Syndromes

Foodborne illness outbreaks most often involve norovirus

Foodborne illness outbreaks most commonly involve norovirus, according to research published in the June 2 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Diseases, Conditions, Syndromes

Nirmatrelvir-ritonavir effective for outpatient treatment of COVID-19

For outpatient treatment of COVID-19, nirmatrelvir-ritonavir is effective for reducing 30-day hospitalization or death, while molnupiravir is associated with a reduction in 30-day mortality, according to a study published ...